Baudax Bio, Inc. (BXRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 21, 2025, 4:00 PM EDT
Baudax Bio Market Cap
Baudax Bio has a market cap or net worth of $52.00 as of August 22, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
52.00
Enterprise Value
n/a
Revenue
1.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 18, 2019, Baudax Bio's market cap has decreased from 54.92M to 52.00, a decrease of -100.00%. That is a compound annual growth rate of -91.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 52.00 | - |
| Dec 31, 2024 | 52.00 | -100.00% |
| Dec 29, 2023 | 1.15M | -34.59% |
| Dec 30, 2022 | 1.76M | -90.48% |
| Dec 31, 2021 | 18.54M | -30.04% |
| Dec 31, 2020 | 26.50M | -59.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 626.52M |
| Elite Pharmaceuticals | 603.43M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |